InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,195.72
(
0.29%
)
US TECH 100
17,674.00
(
0.36%
)
Dow Jones
38,921.04
(
0.18%
)
Brent Oil
83.38
(
-0.12%
)
Bitcoin
63,449.55
(
0.45%
)
Post# of 3309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

GTF

Send PM Follow Ignore
Followers 21
Posts 1886
Boards Moderated 0
Alias Born 03/22/2017

GTF

Member Level

Re: TClap post# 1718

Tuesday, 02/06/2018 5:41:42 PM

Tuesday, February 06, 2018 5:41:42 PM

Post# of 3309
I was hoping the presser would be to say that the phase 1 result warranted skipping phase 2 right to phase 3.

If the FDA issues a strong positive opinion this stock could go to a $100 in a buyout IMO.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ATOS News
More ATOS News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!